Wańkowicz, P.; Staszewski, J.; Dębiec, A.; Nowakowska-Kotas, M.; Szylińska, A.; Rotter, I.
Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants. J. Clin. Med. 2021, 10, 1223.
https://doi.org/10.3390/jcm10061223
AMA Style
Wańkowicz P, Staszewski J, Dębiec A, Nowakowska-Kotas M, Szylińska A, Rotter I.
Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants. Journal of Clinical Medicine. 2021; 10(6):1223.
https://doi.org/10.3390/jcm10061223
Chicago/Turabian Style
Wańkowicz, Paweł, Jacek Staszewski, Aleksander Dębiec, Marta Nowakowska-Kotas, Aleksandra Szylińska, and Iwona Rotter.
2021. "Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants" Journal of Clinical Medicine 10, no. 6: 1223.
https://doi.org/10.3390/jcm10061223
APA Style
Wańkowicz, P., Staszewski, J., Dębiec, A., Nowakowska-Kotas, M., Szylińska, A., & Rotter, I.
(2021). Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants. Journal of Clinical Medicine, 10(6), 1223.
https://doi.org/10.3390/jcm10061223